CLASP II TR, TriBAND, bRIGHT: Late-Breaking Trials on tricuspid intervention

Session comprising selected PCR London Valves 2022 Late-Breaking Trial submissions

Anchorperson: A. Latib
Moderator: N. Dumonteil
SHOW MORE

Summary

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions in this session: the CLASP II TR on transcatheter tricuspid valve repair, the TriBAND study one-year outcomes on transcatheter tricuspid annular reduction, and the bRIGHT trial on real-world outcomes for TEER.

Presentations available when logged in:

  • Transcatheter tricuspid valve repair: the CLASP II TR trial roll-in cohort
  • Transcatheter tricuspid annular reduction: The TriBAND study one-year outcomes
  • Real-world outcomes for tricuspid edge-to-edge repair: initial one-year outcomes from the bRIGHT trial